Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
IgY is the major antibody found in birds (including chickens), reptiles, and lungfish. It is functionally analogous to mammalian immunoglobulin G (IgG) but differs structurally and immunologically. IgY is typically extracted from the egg yolks of hens that have been immunized with specific antigens, resulting in antigen-specific polyclonal antibodies. These antibodies are used for passive immunotherapy and prophylaxis against a wide range of infectious diseases in humans and animals. Mechanism of action involves highly specific antigen-antibody interactions at mucosal surfaces or systemically: - Inhibition of microbial adhesion to host cells - Suppression of viral colonization by preventing cell-to-cell spread - Agglutination and immobilization of pathogens - Inhibition of pathogen enzyme activity - Neutralization of toxins IgY has been studied for prevention or treatment of dental caries, periodontitis, gastritis caused by Helicobacter pylori, oral thrush (Candida albicans), infant rotavirus diarrhea, tuberculosis (Mycobacterium tuberculosis), Acinetobacter baumannii infections including pneumonia/sepsis/UTI/wound infection, Pseudomonas aeruginosa infections including as an adjuvant in cancer therapy or sepsis models. It has also shown efficacy against viruses such as Influenza A virus, Rotavirus, Dengue virus, Zika virus, Ebola virus; parasites like Trypanosoma cruzi; fungi like Candida albicans; and various foodborne pathogens. Advantages include high specificity to target pathogens without disturbing normal flora or causing resistance development seen with antibiotics. IgY can be produced rapidly at scale using egg-laying hens with minimal environmental impact[1][2][3][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on IgY.